Boryung Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Boryung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company's products include antibiotics, dermatology drugs, cardiovascular drugs, antineoplastics, antiemetics, urology drugs, gastrointestinal drugs, antipyretic drugs, analgesics, anti-inflammatory drugs, amino acids injections, dialysis drugs, antidiabetics, central nervous system (CNS) drugs, vaccines and other pharmaceuticals. The Company also offers active pharmaceutical ingredients (API) products, including doxorubicin hydrochloride, epirubicin hydrochloride, captopril, alacepril, nitrendipine, fluconazole, ondansetron hydrochloride, tamsulosin hydrochloride, glimepiride, alibendole, torsemide, domepezil and topiramate. In 2010, the Company had 10 subsidiaries and associated companies. In
our complete report available for purchase the company is compared to: Handok Pharmaceuticals Co., Ltd., LG Life Sciences Ltd and Shin Poong Pharmaceutical Co., Ltd..